SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-21-001289
Filing Date
2021-02-19
Accepted
2021-02-19 16:15:45
Documents
12
Period of Report
2021-02-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A edit-20210204x8ka.htm   iXBRL 8-K/A 33743
  Complete submission text file 0001558370-21-001289.txt   151155

Data Files

Seq Description Document Type Size
2 EX-101.SCH edit-20210204.xsd EX-101.SCH 2999
3 EX-101.LAB edit-20210204_lab.xml EX-101.LAB 15384
4 EX-101.PRE edit-20210204_pre.xml EX-101.PRE 9975
5 EXTRACTED XBRL INSTANCE DOCUMENT edit-20210204x8ka_htm.xml XML 4634
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37687 | Film No.: 21655771
SIC: 2836 Biological Products, (No Diagnostic Substances)